Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Azitra Inc Common Stock (NY:AZTR)

0.9720 -0.0980 (-9.16%)
Official Closing Price Updated: 4:10 PM EDT, Sep 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Azitra Inc Common Stock

< Previous 1 2 3 4 5 Next >
Nasdaq Down 2%; Alphabet Posts Upbeat Earnings
 
Via Benzinga
Why Is Conn’s (CONN) Stock Down 36% Today?
Conn’s stock is falling on Wednesday as CONN investors react to reports of potential store closures and a bankruptcy filing. 
Via InvestorPlace
Topics Bankruptcy
Why Is Azitra (AZTR) Stock Down 75% Today?
Azitra stock is falling on Wednesday as shares of AZTR come off of a massive rally yesterday alongside a new patent update. 
Via InvestorPlace
Topics Intellectual Property
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time to dive into the biggest pre-market stock movers for Wednesday as we check out all of the hottest news to start the day with! 
Via InvestorPlace
Why Azitra (AZTR) Shares Are Down 29% Today
Azitra shares are trading lower by 29% during Tuesday's session. The company announced a mixed shelf offering of up to $50 million. 
Via Benzinga
AZTR Stock Earnings: Anitra Beats EPS for Q4 2023
AZTR stock results show that Anitra beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
Why Enphase Energy Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Azitra, Inc. Announces Pricing of $10.0 Million Public Offering
From Azitra, Inc.
Via Business Wire
Gold Moves Higher; Coca-Cola Increases FY24 Forecast
 
Via Benzinga
Why Is Azitra (AZTR) Stock Up 315% Today?
Azitra stock is up on Tuesday alongside heavy trading of AZTR shares after it provided investors with an update on new patents. 
Via InvestorPlace
Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
 
Via Benzinga
Why Azitra Stock Is Moving Higher On Tuesday
Azitra announced that the U.S. Patent and Trademark Office granted it's patent application regarding the treatment of atopic dermatitis. 
Via Benzinga
Topics Intellectual Property
Crude Oil Down 2%; GE Aerospace Earnings Top Views
 
Via Benzinga
US Stocks Edge Higher; General Motors Posts Upbeat Earnings
 
Via Benzinga
Azitra, Inc. Strengthens Global Intellectual Property Portfolio with Newly Granted and Allowed Patents
From Azitra, Inc.
Via Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Pre-market stock movers are a hot topic on Friday and we're breaking down all of the latest news sending shares higher and lower! 
Via InvestorPlace
Azitra, Inc. Announces Reverse Stock Split
From Azitra, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Tuesday morning! 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
Azitra, Inc. Announces Presentation at the 2024 BIO International Convention
From Azitra, Inc.
Via Business Wire
Azitra, Inc. Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual Meeting
From Azitra, Inc.
Via Business Wire
Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting
From Azitra, Inc.
Via Business Wire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.